| Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy M Zangari, E Anaissie, B Barlogie, A Badros, R Desikan, AV Gopal, ... Blood, The Journal of the American Society of Hematology 98 (5), 1614-1615, 2001 | 605 | 2001 |
| Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes R Govindarajan, L Ratnasinghe, DL Simmons, ER Siegel, MV Midathada, ... Journal of Clinical Oncology 25 (12), 1476, 2007 | 403 | 2007 |
| Randomized phase II trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-trastuzumab in uterine serous carcinomas that overexpress human epidermal growth factor … AN Fader, DM Roque, E Siegel, N Buza, P Hui, O Abdelghany, ... Journal of Clinical Oncology 36 (20), 2044-2051, 2018 | 375 | 2018 |
| Results of autologous stem cell transplant in multiple myeloma patients with renal failure A Badros, B Barlogie, E Siegel, J Roberts, C Langmaid, M Zangari, ... British journal of haematology 114 (4), 822-829, 2001 | 354 | 2001 |
| Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy M Zangari, E Siegel, B Barlogie, E Anaissie, F Saghafifar, A Fassas, ... Blood, The Journal of the American Society of Hematology 100 (4), 1168-1171, 2002 | 333 | 2002 |
| Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years A Badros, B Barlogie, E Siegel, C Morris, R Desikan, M Zangari, A Fassas, ... British journal of haematology 114 (3), 600-607, 2001 | 281 | 2001 |
| Gene expression profiles of primary HPV16-and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers … AD Santin, F Zhan, E Bignotti, ER Siegel, S Cané, S Bellone, M Palmieri, ... Virology 331 (2), 269-291, 2005 | 246 | 2005 |
| Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioning A Badros, B Barlogie, E Siegel, M Cottler-Fox, M Zangari, A Fassas, ... Journal of clinical oncology 20 (5), 1295-1303, 2002 | 242 | 2002 |
| Modulation of lipid biosynthesis contributes to stress resistance and longevity of C. elegans mutants RJS Reis, L Xu, H Lee, M Chae, JJ Thaden, P Bharill, C Tazearslan, ... Aging (Albany NY) 3 (2), 125, 2011 | 199 | 2011 |
| Amplification of c‐erbB2 oncogene: a major prognostic indicator in uterine serous papillary carcinoma AD Santin, S Bellone, S Van Stedum, W Bushen, M Palmieri, ER Siegel, ... Cancer 104 (7), 1391-1397, 2005 | 195 | 2005 |
| Randomized phase II trial of carboplatin–paclitaxel compared with carboplatin–paclitaxel–trastuzumab in advanced (stage III–IV) or recurrent uterine serous carcinomas that … AN Fader, DM Roque, E Siegel, N Buza, P Hui, O Abdelghany, ... Clinical Cancer Research 26 (15), 3928-3935, 2020 | 192 | 2020 |
| Mobilization of CD34+ cells in elderly patients (≥ 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen CL Morris, E Siegel, B Barlogie, M Cottler‐Fox, P Lin, A Fassas, M Zangari, ... British journal of haematology 120 (3), 413-423, 2003 | 191 | 2003 |
| Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial AD Santin, S Bellone, M Palmieri, A Zanolini, A Ravaggi, ER Siegel, ... Journal of virology 82 (4), 1968-1979, 2008 | 183 | 2008 |
| Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast … CA Cooney, F Jousheghany, A Yao-Borengasser, B Phanavanh, ... Breast cancer research 13 (3), 1-15, 2011 | 182 | 2011 |
| Actiated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic … M Zangari, F Saghafifar, E Anaissie, A Badros, R Desikan, A Fassas, ... Blood coagulation & fibrinolysis 13 (3), 187-192, 2002 | 178 | 2002 |
| Treatment of chemotherapy-resistant human ovarian cancer xenografts in CB-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin AD Santin, S Cané, S Bellone, M Palmieri, ER Siegel, M Thomas, ... Cancer research 65 (10), 4334-4342, 2005 | 151 | 2005 |
| In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control … MA Moreno, BS Edeiken-Monroe, ER Siegel, SI Sherman, GL Clayman Thyroid 22 (4), 347-355, 2012 | 139 | 2012 |
| In vivo liquid biopsy using Cytophone platform for photoacoustic detection of circulating tumor cells in patients with melanoma EI Galanzha, YA Menyaev, AC Yadem, M Sarimollaoglu, MA Juratli, ... Science translational medicine 11 (496), eaat5857, 2019 | 137 | 2019 |
| Cricopharyngeal dysfunction: a systematic review comparing outcomes of dilatation, botulinum toxin injection, and myotomy P Kocdor, ER Siegel, OE Tulunay‐Ugur The Laryngoscope 126 (1), 135-141, 2016 | 136 | 2016 |
| Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer AD Santin, S Bellone, ER Siegel, M Palmieri, M Thomas, MJ Cannon, ... American journal of obstetrics and gynecology 192 (3), 813-818, 2005 | 136 | 2005 |
Sergio PecorelliProfessor Of Gynecology and Obstetrics, University of Brescia, ItalyVerified email at unibs.it
